Analysts consider Ebos’ result a solid one

Analysts consider Ebos’ result a solid one
Jarden analysts have upgraded their rating for Ebos. (Image: Getty)
Ella Somers
Analysts feel upbeat but cautious about the future after healthcare wholesaler Ebos posted a better-than-expected full-year result on Wednesday.Jarden analysts Adrian Allbon and Nick Yeo upgraded their rating from underweight to neutral for the company.“Underlying cashflows were stronger than expected, with a beat on final dividend and lower net debt versus our expectations,” they wrote.Jarden's other highlights for the company included the LifeHealthcare acquisition performing “in line” with management expectations...

More Markets

NZ sharemarket up 0.4% after a2 Milk surge
Markets Market Close

NZ sharemarket up 0.4% after a2 Milk surge

The S&P/NZX 50 Index closed at 12,266.25, gaining 57.2 points or 0.47%.

Graham Skellern 14 Mar 2025
Goldman Sachs downgrades Fletcher Building to sell
Markets

Goldman Sachs downgrades Fletcher Building to sell

Goldman Sach analysts have a 12-month target price of A$2.85 ($3.14).

Rebecca Howard 14 Mar 2025
Rayonier exits NZ with $1.2b forestry sale
Primary Sector

Rayonier exits NZ with $1.2b forestry sale

An investment firm bought the stake, which included 116,145 hectares of forestry.

John Anthony 14 Mar 2025
NZME board told 'compromise or be rolled'
Markets

NZME board told 'compromise or be rolled'

Minority shareholders are falling in behind billionaire Jim Grenon's board coup.